SKI Market

Indian Indices

Sensex

82,269.78 -296.59
( -0.36%)

Global Indices

Nasdaq

48,928.31 -164.26
(-0.33%)

Dow Jones

6,963.16 -26.85
(-0.38%)

Hang Seng

53,392.10 16.50
(0.03%)

Nikkei 225

10,214.90 43.14
(0.42%)

Forex

USD-INR

91.92 0.08
(0.09%)

EUR-INR

109.97 0.03
(0.03%)

GBP-INR

126.94 0.27
(0.21%)

JPY-INR

0.60 0.00
(0.00%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

C2C Advanced Systems Ltd

Industry : Engineering

BSE Code

ISIN Demat

Book Value()

93016

INE0U7V01015

127.6508352

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

C2C

22.73

655.75

EPS(TTM)

Face Value()

Div & Yield %

Back

mrf ltd

Bacil Pharma standalone net profit declines 97.92% in the September 2025 quarter

Nov 14,2025

Net profit of Bacil Pharma declined 97.92% to Rs 0.01 crore in the quarter ended September 2025 as against Rs 0.48 crore during the previous quarter ended September 2024. There were no Sales reported in the quarter ended September 2025 and during the previous quarter ended September 2024.

82,269.78 -296.59 ( -0.36%)

48,928.31 -164.26 (-0.33%)

6,963.16 -26.85 (-0.38%)

53,392.10 16.50 (0.03%)

10,214.90 43.14 (0.42%)

91.92 0.08 (0.09%)

109.97 0.03 (0.03%)

126.94 0.27 (0.21%)

0.60 0.00 (0.00%)